ABI
ELV icon

Adamant Biomedical Investments’s Elevance Health ELV Stock Holding History

Adamant Biomedical Investments’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$3.77M Sell
30,000
-8,000
-21% -$989K 0.9% 43
2014
Q3 		$4.55M Buy
+38,000
New +$4.36M 1.13% 34

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Adamant Biomedical Investments's ELV Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Elevance Health (ELV) stake by 21% in Q4 2014, selling an estimated $989K and leaving 30,000 shares worth $3.77M. The position accounts for 0.9% of the portfolio, ranked #43.

Adamant Biomedical Investments first reported a position in ELV in Q3 2014 and has held it in 2 quarters since. The position peaked at $4.55M in Q3 2014. 719 funds tracked by Wall St. Rank hold ELV as of Q4 2014.

  • Adamant Biomedical Investments held 30,000 shares of Elevance Health worth $3.77M as of Q4 2014.
  • Adamant Biomedical Investments sold 8,000 Elevance Health shares in Q4 2014, an estimated $989K.
  • Elevance Health made up 0.9% of Adamant Biomedical Investments's portfolio in Q4 2014, its #43 holding.
  • Adamant Biomedical Investments first reported a position in Elevance Health in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's Elevance Health position peaked at $4.55M in Q3 2014.
  • 719 funds tracked by Wall St. Rank held Elevance Health as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.